Beijing Wantai Biological Pharmacy Enterprise Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 11.64%

Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) has an Asset Resilience Ratio of 11.64% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥1.60 Billion

≈ $234.35 Million USD Cash + Short-term Investments

Total Assets

CN¥13.76 Billion

≈ $2.01 Billion USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2013–2025)

This chart shows how Beijing Wantai Biological Pharmacy Enterprise Co Ltd's Asset Resilience Ratio has changed over time. Check 603392 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Beijing Wantai Biological Pharmacy Enterprise Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Beijing Wantai Biological Pharmacy Enter.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.60 Billion	11.64%
Total Liquid Assets	CN¥1.60 Billion	11.64%

Asset Resilience Insights

Moderate Liquidity: Beijing Wantai Biological Pharmacy Enterprise Co Ltd has 11.64% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Beijing Wantai Biological Pharmacy Enterprise Co Ltd Industry Peers by Asset Resilience Ratio

Compare Beijing Wantai Biological Pharmacy Enterprise Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Akero Therapeutics Inc NASDAQ:AKRO	Biotechnology	55.87%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Zealand Pharma A/S CO:ZEAL	Biotechnology	63.98%
Verona Pharma PLC ADR NASDAQ:VRNA	Biotechnology	0.00%
Immunitybio Inc NASDAQ:IBRX	Biotechnology	38.07%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%

Annual Asset Resilience Ratio for Beijing Wantai Biological Pharmacy Enterprise Co Ltd (2013–2025)

The table below shows the annual Asset Resilience Ratio data for Beijing Wantai Biological Pharmacy Enterprise Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	10.30%	CN¥1.45 Billion ≈ $211.76 Million	CN¥14.04 Billion ≈ $2.06 Billion	-6.78pp
2024-12-31	17.09%	CN¥2.51 Billion ≈ $367.30 Million	CN¥14.69 Billion ≈ $2.15 Billion	+1.46pp
2023-12-31	15.62%	CN¥2.46 Billion ≈ $359.30 Million	CN¥15.71 Billion ≈ $2.30 Billion	+3.25pp
2022-12-31	12.38%	CN¥2.01 Billion ≈ $293.92 Million	CN¥16.23 Billion ≈ $2.37 Billion	+11.80pp
2021-12-31	0.57%	CN¥40.39 Million ≈ $5.91 Million	CN¥7.05 Billion ≈ $1.03 Billion	-0.86pp
2020-12-31	1.44%	CN¥50.36 Million ≈ $7.37 Million	CN¥3.50 Billion ≈ $512.70 Million	-1.24pp
2019-12-31	2.68%	CN¥58.00 Million ≈ $8.49 Million	CN¥2.16 Billion ≈ $316.80 Million	+2.66pp
2018-12-31	0.02%	CN¥343.70K ≈ $50.29K	CN¥1.81 Billion ≈ $265.54 Million	-0.02pp
2017-12-31	0.04%	CN¥671.42K ≈ $98.25K	CN¥1.66 Billion ≈ $242.29 Million	0.00pp
2016-12-31	0.04%	CN¥619.72K ≈ $90.68K	CN¥1.45 Billion ≈ $212.83 Million	+0.02pp
2015-12-31	0.03%	CN¥301.31K ≈ $44.09K	CN¥1.10 Billion ≈ $161.20 Million	+0.02pp
2014-12-31	0.01%	CN¥64.47K ≈ $9.43K	CN¥805.50 Million ≈ $117.87 Million	-0.01pp
2013-12-31	0.02%	CN¥121.71K ≈ $17.81K	CN¥606.98 Million ≈ $88.82 Million	--

pp = percentage points

About Beijing Wantai Biological Pharmacy Enterprise Co Ltd

SHG:603392 China Biotechnology

Market Cap

$5.66 Billion

CN¥38.69 Billion CNY

Market Cap Rank

#3259 Global

#421 in China

Share Price

CN¥30.60

Change (1 day)

-0.13%

52-Week Range

CN¥26.27 - CN¥62.34

All Time High

CN¥142.90